• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项使用特征值(EVA)方法对磺胺类药物结构与其碳酸酐酶抑制活性之间关系的定量构效关系(QSAR)研究。

A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method.

作者信息

Oltulu Oral, Yaşar Mehmet M, Eroğlu Erol

机构信息

Harran University, Physics Department, Osmanbey Kampus, 6300 Sanliurfa, Turkey.

出版信息

Eur J Med Chem. 2009 Sep;44(9):3439-44. doi: 10.1016/j.ejmech.2009.02.016. Epub 2009 Feb 21.

DOI:10.1016/j.ejmech.2009.02.016
PMID:19303173
Abstract

In this study, we present an application of EVA descriptors for a QSAR model of inhibition of carbonic anhydrase isozyme CA II by an heterogeneous set of 66 sulfonamide compounds. For each of the compounds, geometry optimization and frequency calculations have been performed using the DFT/B3LYP level of the theory in conjugated with the 6-31G* basis set. Different numbers of EVA descriptors for each structure were produced by applying various values of Gaussian kernel of a fixed standard deviation, sigma (cm(-1)) and sampled at fixed increments of L (cm(-1)) during the evaluation of the descriptors based on their vibrational frequencies. The set of compounds was divided into two subsets. The first subset contained the 22 compounds that were used as the test compounds. The remaining 44 compounds were used as the training set. Several QSAR models have been developed using these calculated EVA descriptors and the carbonic anhydrase isozyme CA II inhibitory data (K(i)) of the compounds. Among the QSAR models evaluated, the one that produced the best statistical results had the parameters sigma and L both equal to 5 cm(-1). This model produced correlation values (R(2)) of 0.777 and 0.616 for the training and test sets, respectively. The results of this study showed that EVA descriptors perform well as explanatory and predictive tools for modeling the inhibition activity of carbonic anhydrase by a set of sulfonamide compounds.

摘要

在本研究中,我们展示了将EVA描述符应用于由66种磺酰胺化合物组成的异构集对碳酸酐酶同工酶CA II抑制作用的QSAR模型。对于每种化合物,使用密度泛函理论(DFT)/B3LYP水平结合6-31G*基组进行了几何优化和频率计算。通过应用固定标准偏差sigma(cm⁻¹)的高斯核的不同值,并在基于其振动频率评估描述符期间以固定的L(cm⁻¹)增量进行采样,为每个结构生成了不同数量的EVA描述符。该化合物集被分为两个子集。第一个子集包含用作测试化合物的22种化合物。其余44种化合物用作训练集。使用这些计算出的EVA描述符和化合物的碳酸酐酶同工酶CA II抑制数据(K(i))开发了几个QSAR模型。在评估的QSAR模型中,产生最佳统计结果的模型的参数sigma和L均等于5 cm⁻¹。该模型对训练集和测试集的相关值(R²)分别为0.777和0.616。本研究结果表明,EVA描述符作为一组磺酰胺化合物对碳酸酐酶抑制活性建模的解释和预测工具表现良好。

相似文献

1
A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method.一项使用特征值(EVA)方法对磺胺类药物结构与其碳酸酐酶抑制活性之间关系的定量构效关系(QSAR)研究。
Eur J Med Chem. 2009 Sep;44(9):3439-44. doi: 10.1016/j.ejmech.2009.02.016. Epub 2009 Feb 21.
2
A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II.基于密度泛函理论的量子理论定量构效关系研究:芳香族和杂环磺酰胺类化合物作为碳酸酐酶同工酶CA-II抑制剂的研究
J Mol Graph Model. 2007 Nov;26(4):701-8. doi: 10.1016/j.jmgm.2007.03.015. Epub 2007 Apr 4.
3
Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.量子化学定量构效关系模型区分磺胺类药物对人碳酸酐酶 I 和 II 以及牛碳酸酐酶 IV 同工酶的抑制活性。
Chem Biol Drug Des. 2012 Apr;79(4):514-22. doi: 10.1111/j.1747-0285.2011.01309.x. Epub 2012 Jan 30.
4
QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices.利用拓扑信息指数对作为碳酸酐酶II抑制剂的对取代芳基磺酰胺进行定量构效关系研究。
Bioorg Med Chem. 2006 Feb 15;14(4):1108-14. doi: 10.1016/j.bmc.2005.09.038. Epub 2005 Oct 5.
5
3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.人碳酸酐酶II磺酰胺抑制剂的3D-QSAR研究
Eur J Med Chem. 2007 Mar;42(3):365-72. doi: 10.1016/j.ejmech.2006.09.022. Epub 2006 Nov 21.
6
A physically interpretable quantum-theoretic QSAR for some carbonic anhydrase inhibitors with diverse aromatic rings, obtained by a new QSAR procedure.通过一种新的定量构效关系(QSAR)程序获得了一种针对某些具有不同芳香环的碳酸酐酶抑制剂的具有物理可解释性的量子理论QSAR。
Bioorg Med Chem. 2005 Mar 15;13(6):2197-211. doi: 10.1016/j.bmc.2004.12.055.
7
3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.苯磺酰胺类似物作为碳酸酐酶 II 抑制剂的 3D-QSAR 研究。
Bioorg Med Chem Lett. 2010 May 15;20(10):3089-93. doi: 10.1016/j.bmcl.2010.03.104.
8
QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.用一系列磺胺类药物对人碳酸酐酶跨膜同工酶XII和XIV抑制作用的定量构效关系研究
Bioorg Med Chem. 2007 Sep 1;15(17):5666-71. doi: 10.1016/j.bmc.2007.06.009. Epub 2007 Jun 8.
9
Use of 3D QSAR models for database screening: a feasibility study.用于数据库筛选的3D QSAR模型:一项可行性研究。
J Chem Inf Model. 2008 Feb;48(2):384-96. doi: 10.1021/ci7002945. Epub 2008 Jan 23.
10
QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.碳酸酐酶抑制剂的定量构效关系研究:含8-喹啉磺酰基部分的芳香族/杂环磺酰胺类化合物,具有作为抗青光眼药物的局部活性。
Eur J Med Chem. 2004 Jul;39(7):593-600. doi: 10.1016/j.ejmech.2004.03.002.